Vaxcyte, Inc. - PCVX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$10.22B

QoQ value delta ($000)

+$3.607B (+54.54%)

Implied price effect (QoQ)

+23.88%

Total shares

178,785,496

QoQ shares delta

+35,464,980 (+24.75%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 340 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
JANUS HENDERSON GROUP PLC	960,231	16,575,875	0.46%
FMR LLC	958,400	16,492,861	0.05%
T. Rowe Price Investment Management, Inc.	704,643	12,126,017	0.49%
RA CAPITAL MANAGEMENT, L.P.	666,788	11,474,599	7.07%
BlackRock, Inc.	637,572	10,971,816	0.01%
VANGUARD GROUP INC	562,630	12,193,986	0.01%
VANGUARD PORTFOLIO MANAGEMENT LLC	364,904	6,279,545	0.02%
VANGUARD CAPITAL MANAGEMENT LLC	364,157	6,266,701	0.01%
WELLINGTON MANAGEMENT GROUP LLP	326,264	5,614,597	0.06%
Paradigm Biocapital Advisors LP	278,522	4,793,020	5.69%
STATE STREET CORP	258,038	4,440,519	0.01%
Deep Track Capital, LP	249,873	4,300,000	4.08%
WESTFIELD CAPITAL MANAGEMENT CO LP	211,877	3,646,138	0.89%
GEODE CAPITAL MANAGEMENT, LLC	186,061	3,201,283	0.01%
Kynam Capital Management, LP	169,816	2,922,335	10.48%
D. E. Shaw & Co., Inc.	166,503	2,865,318	0.1%
Caligan Partners LP	119,748	2,060,719	7.97%
JENNISON ASSOCIATES LLC	98,671	1,698,011	0.07%
Polar Capital Holdings Plc	82,852	1,425,788	0.29%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	81,583	1,403,948	0.01%
MAVERICK CAPITAL LTD	80,060	1,377,738	0.92%
EVENTIDE ASSET MANAGEMENT, LLC	79,840	1,374,292	1.32%
Pivotal bioVenture Partners Investment Advisor LLC	79,751	1,372,425	28.51%
UBS Group AG	77,715	1,337,390	0.01%
GOLDMAN SACHS GROUP INC	75,550	1,300,136	0.01%